NEOSTIGMINE News
NEOSTIGMINE currently has 0 news articles, with 13 predicted indications.
This page combines the AI-predicted indications for NEOSTIGMINE with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (13):
- adult-onset myasthenia gravis (99.0%)
- neuromuscular junction disease (99.0%)
- myasthenia gravis (99.0%)
- myasthenia gravis with thymus hyperplasia (100.0%)
- myasthenia, limb-girdle, autoimmune (100.0%)
- autoimmune disease of peripheral nervous system (100.0%)
- neonatal myasthenia gravis (100.0%)
- disease of receptor activity (100.0%)
- hypersplenism (disease) (99.9%)
- atypical hemolytic-uremic syndrome with B factor anomaly (99.8%)
- bronchitis (99.8%)
- fetal akinesia deformation sequence (99.7%)
- myasthenia, congenital, refractory to acetylcholinesterase inhibitors (99.4%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.